48,454
edits
Difference between revisions of "Cancer drugs"
Jump to navigation
Jump to search
m
→Drugs in a table
| Line 24: | Line 24: | ||
| Iressa | | Iressa | ||
| 3496 Euros/month<ref name=spiegel8_8_11_124/> | | 3496 Euros/month<ref name=spiegel8_8_11_124/> | ||
| [[ | | [[lung cancer]] | ||
| EGFR inhibitor - like erlotinib | | EGFR inhibitor - like erlotinib | ||
|- | |- | ||
| Line 51: | Line 51: | ||
| tyrosine kinase inhibitor | | tyrosine kinase inhibitor | ||
|- | |- | ||
| | | dasatinib | ||
| Sprycel | | Sprycel | ||
| 7513 Euros/month<ref name=spiegel8_8_11_124/> | | 7513 Euros/month<ref name=spiegel8_8_11_124/> | ||
| ALL, CML | | ALL, CML | ||
| | | tyrosine kinase inhibitor | ||
|- | |- | ||
| nilotinib | | nilotinib | ||